Design Therapeutics, Inc.
DSGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807120
No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Design Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 97 | 87 | −10 |
| Shares | 38.8M | 32.9M | −5.92M (−15.3%) |
| Value | $244.4M | $77.6M | −$166.8M (−68.3%) |
New holders (14)
Institutions that held Design Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 1,350,000 | $3.19M | 0.45% |
| Prosight Management, LP | 1,203,745 | $2.84M | 0.90% |
| Soleus Capital Management, L.P. | 1,025,000 | $2.42M | 0.24% |
| Prescott Group Capital Management, L.L.C. | 180,000 | $425.0K | 0.09% |
| Occudo Quantitative Strategies LP | 100,722 | $237.7K | 0.03% |
| Bridgeway Capital Management, LLC | 80,500 | $190.0K | 0.00% |
| STRS Ohio | 72,800 | $171.0K | 0.00% |
| HSBC Holdings PLC | 36,490 | $85.6K | 0.00% |
| Prelude Capital Management, LLC | 33,400 | $78.8K | 0.01% |
| Graham Capital Management, L.P. | 21,850 | $51.6K | 0.00% |
| SG Americas Securities, LLC | 19,907 | $47.0K | 0.00% |
| Glassman Wealth Services | 565 | $1.33K | 0.00% |
| Comerica Bank | 549 | $1.30K | 0.00% |
| Nisa Investment Advisors, LLC | 30 | $71 | 0.00% |
Sold out (24)
Institutions that held Design Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.